The prevalence of side effects with regular and sustained-release nicotinic acid
- 31 October 1995
- journal article
- clinical trial
- Published by Elsevier BV in American Journal Of Medicine
- Vol. 99 (4), 378-385
- https://doi.org/10.1016/s0002-9343(99)80185-5
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Lipoprotein Responses to Treatment With Lovastatin, Gemfibrozil, and Nicotinic Acid in Normolipidemic Patients With HypoalphalipoproteinemiaArchives of Internal Medicine, 1994
- Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Beneficial Effects of Colestipol-Niacin on Coronary AtherosclerosisPublished by American Medical Association (AMA) ,1990
- Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein BNew England Journal of Medicine, 1990
- Reduction of Mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by Combined Treatment with Clofibrate and Nicotinic AcidActa Medica Scandinavica, 1988
- Contrasting effects of unmodified and time-release forms of niacin on lipoproteins in hyperlipidemic subjects: Clues to mechanism of action of niacinMetabolism, 1985
- Clofibrate and Niacin in Coronary Heart DiseaseJAMA, 1975